Trial Details
WITHDRAWNBasic Information
| Clinical ID | c1511 |
|---|---|
| Identifier | NCT00514982 |
| Trial Title | Medical Treatment of Colitis in Patients With Hermansky-Pudlak Syndrome |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Hermanski-Pudlak Syndrome|Colitis|Cytokines|Lymphocytes|Drug Evaluation |
| Interventions | DRUG: Mesalamine|DRUG: Infliximab|DRUG: Corticosteroids|DRUG: 6-Mercaptopurine|DRUG: Tacrolimus|DRUG: Adalimumab |
Participant Information
| Sponsor | National Institute of Allergy and Infectious Diseases (NIAID) |
|---|---|
| City | Bethesda |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2007-08-07 |
|---|---|
| Primary Completion Date | 2011-03-08 |
| Completion Date | 2011-03-08 |